← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2009Last known activity
Jun 1, 2015
Timeline
1990s
- Jan 1, 1998
Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH— Founded
Drugs by trial phase (17 distinct, 13 trials)
Phase 3 (3 own, 0 via acquisition)
Indications
Studied for
- Aggression
- Breast Neoplasms
- Burkitt Lymphoma
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Colorectal Neoplasms
- Disease Progression
- Graft vs Host Disease
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasms, Plasma Cell
- Ovarian Neoplasms
- Preleukemia
- Rectal Neoplasms
- Syndrome
- Thrombocytopenia
- Urinary Bladder Neoplasms
Recent trials (13)
- NCT02335268Lead sponsorPhase 2Jun 1, 2015
- NCT03622931Lead sponsorPhase 2Feb 1, 2014
- NCT01509560Lead sponsorPhase 2Nov 1, 2011
- NCT01418742Lead sponsorPhase 2Aug 1, 2011
- NCT01257360CollaboratorPhase 2Dec 1, 2010
- NCT02983097Lead sponsorPhase 1/Phase 2Nov 1, 2010
- NCT01374789CollaboratorPhase 2Jul 1, 2010
- NCT01320111Lead sponsorPhase 2Jul 1, 2010
- NCT01088620CollaboratorPhase 2Apr 1, 2010
- NCT01081431Lead sponsorPhase 2Mar 1, 2010
- NCT01090089Lead sponsorPhase 3Mar 1, 2010
- NCT01019174Lead sponsorPhase 1/Phase 2Nov 1, 2009
- NCT00891384Lead sponsorPhase 3Apr 1, 2009
Details
- Founded
- Berlin, DE Jan 1, 1998
- Last known activity
- Jun 1, 2015